Literature DB >> 22555213

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Joep Perk1, Guy De Backer, Helmut Gohlke, Ian Graham, Zeljko Reiner, Monique Verschuren, Christian Albus, Pascale Benlian, Gudrun Boysen, Renata Cifkova, Christi Deaton, Shah Ebrahim, Miles Fisher, Giuseppe Germano, Richard Hobbs, Arno Hoes, Sehnaz Karadeniz, Alessandro Mezzani, Eva Prescott, Lars Ryden, Martin Scherer, Mikko Syvänne, Wilma J M Scholte op Reimer, Christiaan Vrints, David Wood, Jose Luis Zamorano, Faiez Zannad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555213     DOI: 10.1093/eurheartj/ehs092

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  992 in total

Review 1.  Developmental actions of natriuretic peptides in the brain and skeleton.

Authors:  J A Waschek
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

2.  Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.

Authors:  Ilaria Ardoino; Raffaella Rossio; Donnatella Di Blanca; Alessandro Nobili; Luca Pasina; Pier Mannuccio Mannucci; Flora Peyvandi; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

3.  Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.

Authors:  Keith C Ferdinand
Journal:  Cardiorenal Med       Date:  2012-10-26       Impact factor: 2.041

4.  LDL cholesterol performance of beta quantification reference measurement procedure.

Authors:  Masakazu Nakamura; Yuzo Kayamori; Hiroyasu Iso; Akihiko Kitamura; Masahiko Kiyama; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Hiroyuki Noda; Mahnaz Dasti; Hubert W Vesper; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2014-02-28       Impact factor: 3.786

5.  Discrepancies between two lipid-lowering guidelines for CVD prevention in seemingly healthy individuals-case study Lebanon.

Authors:  Hussain Ali Isma'eel; Bernard Harbieh; Hani Tamim; Lara Nasreddine; Farah Naja; Abla Sibai; Nada Adra; Kamal Badr; Nahla Hwalla
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

6.  Aspirin Use and Mortality in Two Contemporary US Cohorts.

Authors:  Wen-Yi Huang; Sarah E Daugherty; Meredith S Shiels; Mark P Purdue; Neal D Freedman; Christian C Abnet; Albert R Hollenbeck; Richard B Hayes; Debra T Silverman; Sonja I Berndt
Journal:  Epidemiology       Date:  2018-01       Impact factor: 4.822

7.  Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.

Authors:  Renee Stark; Inge Kirchberger; Matthias Hunger; Margit Heier; Reiner Leidl; Wolfgang von Scheidt; Christa Meisinger; Rolf Holle
Journal:  Clin Res Cardiol       Date:  2013-11-28       Impact factor: 5.460

8.  [New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Authors:  G Klose; F U Beil; H Dieplinger; A von Eckardstein; B Föger; I Gouni-Berthold; W Koenig; G M Kostner; U Landmesser; U Laufs; F Leistikow; W März; M Merkel; D Müller-Wieland; G Noll; K G Parhofer; B Paulweber; W Riesen; J R Schaefer; E Steinhagen-Thiessen; A Steinmetz; H Toplak; C Wanner; E Windler
Journal:  Internist (Berl)       Date:  2014-05       Impact factor: 0.743

9.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

10.  How to manage hyperglycemia in an acute coronary syndrome patient.

Authors:  David Vivas; Esther Bernardo; Julian Palacios-Rubio; Antonio Fernández-Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.